Evidence-Based Oncology ™ is a forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

Standard echocardiographic criteria for grading tricuspid regurgitation (TR) may substantially underestimate the condition's ...

Jørgen Vestbo is a professor of respiratory medicine and an honorary consultant at the North West Lung Centre, Manchester University Hospital NHS Foundation Trust. Jorgen Vestbo, MD, on the COPERNICOS ...

Takeda’s oveporexton (Orzeyful), a selective OX2R agonist, is the first therapy targeting orexin deficiency in NT1, improving ...

While institutional resources such as financial counseling can help, she said such support is not available equally everywhere, and policy changes covering caregiver support and housing could have the ...

Tozorakimab targets IL-33 upstream of TH2 pathways, cutting COPD exacerbations up to 34% in former smokers, Frank Sciurba, MD ...

Fibrotic interstitial lung diseases, like idiopathic pulmonary fibrosis (IPF), commonly overlap with lung cancer—a key ...

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) suggests escalating treatment in patients with chronic ...

UK Biobank data linked 7-day wrist light sensing to CMR 3.1 years later, contrasting >3 lux nighttime exposure with none.

In "Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD," the mental health experts examined ...

Yet H. Khor, MD, PhD, explains why the CPFE index can't replace CT imaging but may help triage which patients need scans. Emphysema extent of 20% or greater on CT imaging was associated with worse ...

Francesca Puggioni, MD, explains how real-world registry data, like the EU-ADVANTAGE study, informs regulatory decisions on ...